{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:04:51Z","timestamp":1786986291231,"version":"build-2736575974"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173045"],"award-info":[{"award-number":["82173045"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.cellsig.2026.112534","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T01:03:29Z","timestamp":1775783009000},"page":"112534","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Analysis of paired primary-metastatic renal cancer lesions reveals RCN3-MMP10 axis facilitates lung metastasis"],"prefix":"10.1016","volume":"144","author":[{"given":"Wenhao","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kandi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siwei","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danfeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yayi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellsig.2026.112534_bb0005","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cancergen.2024.06.002","article-title":"Cancer treatments: past, present, and future","volume":"286-287","author":"Sonkin","year":"2024","journal-title":"Cancer Genet-NY"},{"issue":"3","key":"10.1016\/j.cellsig.2026.112534_bb0010","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.cellsig.2026.112534_bb0015","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g4797","article-title":"Renal cell carcinoma","volume":"349","author":"Jonasch","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.cellsig.2026.112534_bb0020","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2147\/OTT.S56370","article-title":"Clinical impact of targeted therapies in patients with metastatic clear-cell renal cell carcinoma","volume":"7","author":"Nerich","year":"2014","journal-title":"Onco. Targets Ther."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112534_bb0025","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1158\/1535-7163.MCT-17-1299","article-title":"Resistance to systemic therapies in clear cell renal cell carcinoma: mechanisms and management strategies","volume":"17","author":"Makhov","year":"2018","journal-title":"Mol. Cancer Ther."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112534_bb0030","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2020-001079","article-title":"Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 4-year follow-up of the phase III CheckMate 214 trial","volume":"5","author":"Albiges","year":"2020","journal-title":"ESMO Open"},{"issue":"2","key":"10.1016\/j.cellsig.2026.112534_bb0035","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.euo.2024.09.002","article-title":"Neoadjuvant and adjuvant immune-based approach for renal cell carcinoma: pros, cons, and future directions","volume":"8","author":"Marandino","year":"2025","journal-title":"Eur. Urol. Oncol."},{"issue":"11","key":"10.1016\/j.cellsig.2026.112534_bb0040","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.urolonc.2017.06.060","article-title":"Metastatic renal cell carcinoma: patterns and predictors of metastases-a contemporary population-based series","volume":"35","author":"Chandrasekar","year":"2017","journal-title":"Urol. Oncol."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112534_bb0045","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.euo.2018.08.028","article-title":"Surgical metastasectomy in renal cell carcinoma: a systematic review","volume":"2","author":"Ouzaid","year":"2019","journal-title":"Eur. Urol. Oncol."},{"key":"10.1016\/j.cellsig.2026.112534_bb0050","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13045-015-0180-y","article-title":"Role of DNA methylation in renal cell carcinoma","volume":"8","author":"Shenoy","year":"2015","journal-title":"J. Hematol. Oncol."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112534_bb0055","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s40291-018-0337-9","article-title":"The role of DNA methylation in renal cell carcinoma","volume":"22","author":"Lasseigne","year":"2018","journal-title":"Mol. Diagn. Ther."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112534_bb0060","doi-asserted-by":"crossref","first-page":"6659","DOI":"10.1038\/s41467-022-34268-8","article-title":"Cell division drives DNA methylation loss in late-replicating domains in primary human cells","volume":"13","author":"Endicott","year":"2022","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.cellsig.2026.112534_bb0065","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/s41587-021-00910-x","article-title":"Extended-representation bisulfite sequencing of gene regulatory elements in multiplexed samples and single cells","volume":"39","author":"Shareef","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cellsig.2026.112534_bb0070","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/1471-2105-10-232","article-title":"BSMAP: whole genome bisulfite sequence MAPping program","volume":"10","author":"Xi","year":"2009","journal-title":"BMC Bioinformat."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112534_bb0075","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1101\/gr.196394.115","article-title":"Metilene: fast and sensitive calling of differentially methylated regions from bisulfite sequencing data","volume":"26","author":"Juhling","year":"2016","journal-title":"Genome Res."},{"issue":"W1","key":"10.1016\/j.cellsig.2026.112534_bb0080","doi-asserted-by":"crossref","first-page":"W317","DOI":"10.1093\/nar\/gkab447","article-title":"KOBAS-i: intelligent prioritization and exploratory visualization of biological functions for gene enrichment analysis","volume":"49","author":"Bu","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112534_bb0085","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1186\/s12864-015-1847-z","article-title":"MEXPRESS: visualizing expression, DNA methylation and clinical TCGA data","volume":"16","author":"Koch","year":"2015","journal-title":"BMC Genomics"},{"issue":"W1","key":"10.1016\/j.cellsig.2026.112534_bb0090","doi-asserted-by":"crossref","first-page":"W561","DOI":"10.1093\/nar\/gkz445","article-title":"Mexpress update 2019","volume":"47","author":"Koch","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"10.1016\/j.cellsig.2026.112534_bb0095","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1038\/s41596-024-01011-0","article-title":"The HADDOCK2.4 web server for integrative modeling of biomolecular complexes","volume":"19","author":"Honorato","year":"2024","journal-title":"Nat. Protoc."},{"issue":"35","key":"10.1016\/j.cellsig.2026.112534_bb0100","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1200\/JCO.2017.73.5324","article-title":"Randomized phase III trial of adjuvant pazopanib versus placebo after nephrectomy in patients with localized or locally advanced renal cell carcinoma","volume":"35","author":"Motzer","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"23","key":"10.1016\/j.cellsig.2026.112534_bb0105","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1056\/NEJMoa1611406","article-title":"Adjuvant sunitinib in high-risk renal-cell carcinoma after nephrectomy","volume":"375","author":"Ravaud","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112534_bb0110","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2217\/imt-2022-0125","article-title":"Adjuvant therapy in renal cell carcinoma in the immunotherapy era: where do we stand?","volume":"15","author":"Zouein","year":"2023","journal-title":"Immunotherapy-UK"},{"issue":"10358","key":"10.1016\/j.cellsig.2026.112534_bb0115","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/S0140-6736(22)01658-0","article-title":"Adjuvant atezolizumab versus placebo for patients with renal cell carcinoma at increased risk of recurrence following resection (IMmotion010): a multicentre, randomised, double-blind, phase 3 trial","volume":"400","author":"Pal","year":"2022","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.cellsig.2026.112534_bb0120","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cell.2018.03.077","article-title":"Multi-regional sequencing elucidates the evolution of clear cell renal cell carcinoma","volume":"173","author":"Ricketts","year":"2018","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.cellsig.2026.112534_bb0125","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/annonc\/mdw652","article-title":"Differential gene expression profiling of matched primary renal cell carcinoma and metastases reveals upregulation of extracellular matrix genes","volume":"28","author":"Ho","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.cellsig.2026.112534_bb0130","article-title":"Pan-Cancer analysis of the oncogenic and immunological role of RCN3: a potential biomarker for prognosis and immunotherapy","volume":"12","author":"Ding","year":"2022","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112534_bb0135","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.ccell.2020.09.015","article-title":"Single-cell multiomics sequencing reveals prevalent genomic alterations in tumor stromal cells of human colorectal cancer","volume":"38","author":"Zhou","year":"2020","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.cellsig.2026.112534_bb0140","first-page":"293","article-title":"A preliminary study on RCN3 protein expression in non-small cell lung cancer","volume":"62","author":"Hou","year":"2016","journal-title":"Clin. Lab."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112534_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15072008","article-title":"Reticulocalbin 3 is a novel mediator of glioblastoma progression","volume":"15","author":"He","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.cellsig.2026.112534_bb0150","doi-asserted-by":"crossref","first-page":"241","DOI":"10.21873\/cgp.20317","article-title":"Quantitative proteomic analysis of cervical cancer tissues identifies proteins associated with cancer progression","volume":"19","author":"Ramirez-Torres","year":"2022","journal-title":"Cancer Genom. Proteom."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112534_bb0155","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1186\/s12885-023-11303-5","article-title":"Expression signature and prognostic value of CREC gene family in human colorectal cancer","volume":"23","author":"Ning","year":"2023","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.cellsig.2026.112534_bb0160","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1165\/rcmb.2015-0036OC","article-title":"Neonatal respiratory failure with retarded perinatal lung maturation in mice caused by reticulocalbin 3 disruption","volume":"54","author":"Jin","year":"2016","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112534_bb0165","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1165\/rcmb.2017-0347OC","article-title":"Reticulocalbin 3 deficiency in alveolar epithelium exacerbated bleomycin-induced pulmonary fibrosis","volume":"59","author":"Jin","year":"2018","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112534_bb0170","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-023-02533-z","article-title":"TGFbeta1-RCN3-TGFBR1 loop facilitates pulmonary fibrosis by orchestrating fibroblast activation","volume":"24","author":"Wu","year":"2023","journal-title":"Respir. Res."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112534_bb0175","doi-asserted-by":"crossref","first-page":"L627","DOI":"10.1152\/ajplung.00526.2020","article-title":"Reticulocalbin 3 deficiency in alveolar epithelium attenuated LPS-induced ALI via NF-kappaB signaling","volume":"320","author":"Shi","year":"2021","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112534_bb0180","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/bies.200800186","article-title":"The rapidly expanding CREC protein family: members, localization, function, and role in disease","volume":"31","author":"Honore","year":"2009","journal-title":"Bioessays"},{"key":"10.1016\/j.cellsig.2026.112534_bb0185","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cancergen.2025.06.008","article-title":"TRIM29 promotes glioblastoma progression via ubiquitinating NEFL and activating the PI3K\/AKT signaling pathway","volume":"296-297","author":"Liu","year":"2025","journal-title":"Cancer Genet-NY"},{"issue":"3","key":"10.1016\/j.cellsig.2026.112534_bb0190","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.eururo.2006.12.028","article-title":"Expression of matrix metalloproteinase-10 in renal cell carcinoma and its prognostic role","volume":"52","author":"Miyata","year":"2007","journal-title":"Eur. Urol."},{"issue":"3\u20134","key":"10.1016\/j.cellsig.2026.112534_bb0195","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.biochi.2004.12.009","article-title":"Collagenases in cancer","volume":"87","author":"Ala-aho","year":"2005","journal-title":"Biochimie"},{"issue":"4","key":"10.1016\/j.cellsig.2026.112534_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23042131","article-title":"Matrix metalloproteinase-10 in kidney injury repair and disease","volume":"23","author":"Sun","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112534_bb0205","doi-asserted-by":"crossref","DOI":"10.1038\/s41420-024-01946-z","article-title":"MiR-134-5p inhibits the malignant phenotypes of osteosarcoma via ITGB1\/MMP2\/PI3K\/Akt pathway","volume":"10","author":"Yan","year":"2024","journal-title":"Cell Death Discov."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112534_bb0210","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1007\/s11033-022-07184-9","article-title":"MMP-9 secreted by m2-type macrophages promotes wilms\u2019 tumour metastasis through the PI3K\/AKT pathway","volume":"49","author":"Tian","year":"2022","journal-title":"Mol. Biol. Rep."},{"issue":"9","key":"10.1016\/j.cellsig.2026.112534_bb0215","doi-asserted-by":"crossref","first-page":"15847","DOI":"10.1002\/jcp.28242","article-title":"MMP2\/3 promote the growth and migration of laryngeal squamous cell carcinoma via PI3K\/Akt-NF-kappaB-mediated epithelial-mesenchymal transformation","volume":"234","author":"Zhu","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"10","key":"10.1016\/j.cellsig.2026.112534_bb0220","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1021\/acschemneuro.0c00194","article-title":"Manipulating adult neural stem and progenitor cells with G-quadruplex ligands","volume":"11","author":"Goldberg","year":"2020","journal-title":"ACS Chem. Nerosci."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112534_bb0225","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/cbdd.13015","article-title":"Molecular recognition of a carboxy pyridostatin toward g-quadruplex structures: why does it prefer RNA?","volume":"90","author":"Rocca","year":"2017","journal-title":"Chem. Biol. Drug Des."},{"issue":"20","key":"10.1016\/j.cellsig.2026.112534_bb0230","doi-asserted-by":"crossref","first-page":"11426","DOI":"10.1093\/nar\/gkac950","article-title":"RG4detector, a novel RNA g-quadruplex predictor, uncovers their impact on stress granule formation","volume":"50","author":"Turner","year":"2022","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112534_bb0235","article-title":"The voltage-gated sodium channel \u03b23 subunit modulates c6 glioma cell motility independently of channel activity","volume":"1871","author":"Liu","year":"2025","journal-title":"Biochimica et Biophysica Acta. Mol. Basis Dis."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112534_bb0240","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.21037\/jtd-2019-pm-10","article-title":"Pulmonary metastasectomy in renal cell carcinoma: a mainstay of multidisciplinary treatment","volume":"13","author":"Seitlinger","year":"2021","journal-title":"J. Thorac. Dis."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112534_bb0245","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/MOU.0000000000001042","article-title":"Metastasectomy in renal cell carcinoma: where are we now?","volume":"32","author":"Lloyd","year":"2022","journal-title":"Curr. Opin. Urol."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112534_bb0250","doi-asserted-by":"crossref","DOI":"10.1002\/imt2.70070","article-title":"The microbiome in cancer","volume":"4","author":"Lin","year":"2025","journal-title":"iMeta"},{"key":"10.1016\/j.cellsig.2026.112534_bb0255","doi-asserted-by":"crossref","DOI":"10.2174\/0118761429308361240823061634","article-title":"Recent advances in the glycolytic processes linked to tumor metastasis","volume":"17","author":"Qiong","year":"2024","journal-title":"Curr. Mol. Pharmacol."},{"key":"10.1016\/j.cellsig.2026.112534_bb0260","first-page":"1","article-title":"Immunometabolic features and key biomarkers in lung cancer complicated by pulmonary tuberculosis: insights from transcriptome and clinical cohort analysis","author":"Yang","year":"2025","journal-title":"iMetaMed"},{"key":"10.1016\/j.cellsig.2026.112534_bb0265","article-title":"SPP1(+) tam: CD8(+) t cell crosstalk associates with blocking radiotherapy efficacy in lung cancer","volume":"8","author":"Jin","year":"2025","journal-title":"Research (Washington, D. C.)."},{"key":"10.1016\/j.cellsig.2026.112534_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104702","article-title":"A comprehensive review on targeting diverse immune cells for anticancer therapy: beyond immune checkpoint inhibitors","volume":"210","author":"Liu","year":"2025","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112534_bb0275","article-title":"The role of cisplatin in modulating the tumor immune microenvironment and its combination therapy strategies: a new approach to enhance anti-tumor efficacy","volume":"57","author":"Li","year":"2025","journal-title":"Ann. Med."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826001865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826001865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T14:48:52Z","timestamp":1781794132000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656826001865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":55,"alternative-id":["S0898656826001865"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112534","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of paired primary-metastatic renal cancer lesions reveals RCN3-MMP10 axis facilitates lung metastasis","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112534","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"112534"}}